🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 20 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/07/2007 50,40 52,00 49,00 51,50 +4,25% 5,95% 42.900
11/07/2007 47,50 49,70 47,30 49,40 +3,56% 5,05% 25.320
10/07/2007 50,00 50,20 47,20 47,70 -5,17% 6,00% 31.610
09/07/2007 53,00 53,90 49,50 50,30 -1,76% 8,30% 40.940
06/07/2007 50,00 51,90 46,80 51,20 +4,07% 10,20% 46.370
05/07/2007 48,80 50,80 48,50 49,20 -1,60% 4,71% 37.810
03/07/2007 50,00 50,50 49,20 50,00 +1,01% 2,60% 14.440
02/07/2007 51,70 52,80 49,20 49,50 -1,59% 6,96% 67.710
29/06/2007 51,90 51,90 50,10 50,30 -1,18% 3,47% 27.520
28/06/2007 52,40 53,20 50,60 50,90 -2,49% 4,96% 46.090
27/06/2007 52,60 53,90 51,70 52,20 -1,32% 4,18% 54.170
26/06/2007 56,50 56,70 51,70 52,90 -5,54% 8,85% 60.120
25/06/2007 57,70 60,50 55,30 56,00 -1,23% 9,01% 44.470
22/06/2007 61,10 62,30 56,50 56,70 -7,65% 9,49% 311.110
21/06/2007 61,90 62,70 60,60 61,40 +0,24% 3,39% 28.160
20/06/2007 64,50 65,90 60,60 61,25 -5,04% 8,22% 31.210
19/06/2007 66,50 66,50 64,10 64,50 -2,57% 3,61% 17.110
18/06/2007 65,40 67,50 65,00 66,20 -0,60% 3,82% 14.260
15/06/2007 67,60 67,60 64,80 66,60 -1,62% 4,14% 20.930
14/06/2007 67,80 68,00 65,30 67,70 +0,00% 3,98% 13.140
13/06/2007 68,20 68,30 66,00 67,70 +0,74% 3,37% 11.890
12/06/2007 68,00 69,40 66,40 67,20 -1,61% 4,41% 19.840
11/06/2007 67,10 68,90 67,10 68,30 +1,94% 2,68% 11.460
08/06/2007 70,00 70,00 63,60 67,00 -4,29% 9,14% 57.940
07/06/2007 73,00 73,00 69,30 70,00 -4,37% 5,07% 32.620
06/06/2007 73,50 73,50 70,50 73,20 -0,41% 4,08% 22.480
05/06/2007 72,10 74,80 70,40 73,50 +1,38% 6,10% 18.890
04/06/2007 76,00 76,00 70,10 72,50 -2,95% 7,76% 36.880
01/06/2007 76,70 76,90 70,30 74,70 -1,71% 8,60% 54.920
31/05/2007 72,40 76,24 72,40 76,00 +5,70% 5,30% 69.440